| Completed | Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT Leber Congenital Amaurosis (LCA), Retinitis Pigmentosa (RP) | — | 2015-12-01 |
| Completed | Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation Impaired Dark Adaptation | Phase 2 | 2013-11-01 |
| Completed | Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Ep Retinitis Pigmentosa (RP) | Phase 1 | 2012-02-01 |
| Completed | Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extensio LCA (Leber Congenital Amaurosis), RP (Retinitis Pigmentosa) | Phase 1 | 2012-01-01 |
| Completed | Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis LCA (Leber Congenital Amaurosis), RP (Retinitis Pigmentosa) | Phase 1 | 2009-11-01 |
| Completed | Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers Healthy Human Volunteers | Phase 1 | 2008-09-01 |
| Completed | Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) Choroidal Neovascularization, Macular Degeneration | Phase 2 | 2007-07-01 |
| Terminated | A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmac End Stage Renal Disease | Phase 2 | 2006-09-01 |
| Terminated | Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) Prostatic Hyperplasia | Phase 2 | 2005-05-01 |
| Completed | Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | 2003-03-01 |
| Terminated | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as Fi Stage IIIb Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 3 | 2002-06-01 |
| Terminated | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carbop Stage IIIb Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 3 | 2002-06-01 |
| Completed | Visudyne® in Occult (VIO) Macular Degeneration | Phase 3 | 2002-03-01 |
| Completed | Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advance Breast Neoplasms | Phase 2 | 2001-11-01 |
| Completed | Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma Melanoma (Skin) | Phase 1 / Phase 2 | 2000-10-01 |
| Terminated | Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of t Basal Cell Carcinoma, Nevoid Basal Cell Carcinoma Syndrome, Gorlin Syndrome | Phase 3 | — |